Bibliography
Export 14 results:
Filters: Keyword is *Registries [Clear All Filters]
How safe is it to transplant organs from deceased donors with primary intracranial malignancy? An analysis of UK Registry data. Am J Transplant. 2010;10(6):1437-44.
The Spanish National Transplant Organization (ONT) tumor registry. Transplantation. 2008;85(8 Suppl):S61-3.
Analysis of factors that influence survival with post-transplant lymphoproliferative disorder in renal transplant recipients: the Israel Penn International Transplant Tumor Registry experience. Am J Transplant. 2005;5(4 Pt 1):775-80.
Skin cancer following transplantation: the Israel Penn International Transplant Tumor Registry experience. Transplant Proc. 2005;37(2):962-3.
The Israel Penn International Transplant Tumor Registry. AMIA Annu Symp Proc. 2003:1053.
Transplant tumor registry: donors with central nervous system tumors1. Transplantation. 2002;73(4):579-82.
Biologic behavior of carcinoid tumors in solid organ transplant recipients: the Israel Penn international transplant tumor registry experience. Transplant Proc. 2001;33(40762):3656-7.
Kaposi sarcoma: an analysis of the US and international experiences from the Israel Penn International Transplant Tumor Registry. Transplant Proc. 2001;33(40762):3660-1.
First report of the United Network for Organ Sharing Transplant Tumor Registry: donors with a history of cancer. Transplantation. 2000;70(12):1747-51.
Posttransplant malignancies. Transplant Proc. 1999;31(40575):1260-2.
Risk of tumor transmission in transplantation from donors with primary brain tumors: an Australian and New Zealand registry report. Transplant Proc. 1999;31(40575):1266-7.
Malignancy. Surg Clin North Am. 1994;74(5):1247-57.
Neoplastic complications of transplantation. Semin Respir Infect. 1993;8(3):233-9.